Liberty Utilities New York - Lynbrook

PFAS monitoring results for a public water system in New York

NY2902835UCMR 5EPA monitoring data
<MRLHighest PFOA result, ppt
5.1Highest PFOS result, ppt
1.04Highest Hazard Index
1,050Results
PWSID
NY2902835
State
New York
System type
community water system (CWS)
Population served
220,000
City
Merrick
Counties
Nassau County
Primary source water
groundwater
UCMR 5 sampling
2023-04-11 to 2025-08-13 · 18 entry point(s) · water types: GW
Service-area boundary
authoritative

PFOS 1–3 × its limit highest single result
PFOS below its limit worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)<MRL04
PFOS (ppt)5.12.554
Hazard Index1.040.521.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

Compared with New York standards

Highest single resultWorst entry-point average*New York
PFOA (ppt)0010
PFOS (ppt)5.12.5510

Sum standards add the listed compounds within each sample (non-detects = 0). State compliance is normally judged on averages over time; these are screening comparisons.

Sampling history

Sampled 2023-04-11 to 2025-08-13 · 18 entry point(s) · water types: GW · 39 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2023-04-11Wells 15-1A & 15-2A Treatment (GW)SE1<4<40none
2023-04-11Wells 3-1A Treatment (GW)SE1<4<40none
2023-04-11Wells 4-16 & 4-17 Treatment (GW)SE1<4<40none
2023-05-02Well 10-1 Treatment (GW)SE1<4<40none
2023-05-02Wells 12-1 & 12-2 Treatment (GW)SE1n/an/an/anone
2023-05-02Wells 17-1 & 17-2 Treatment (GW)SE1n/an/an/anone
2023-05-17Wells 12-1 & 12-2 Treatment (GW)SE1<4<40none
2023-05-17Wells 17-1 & 17-2 Treatment (GW)SE1<4<40none
2023-06-22Well 2-1A Treatment (GW)SE1<4<40none
2023-06-22Wells 18-1 & 18-2 Treatment (GW)SE1<4<40none
2023-06-22Wells 19-1 & 19-2 Treatment (GW)SE1<4<40none
2023-07-13Well 22-1 Treatment (GW)SE1<4<40none
2023-07-13Well 6-1 Treatment (GW)SE1<4<40lithium 14.9 µg/L
2023-07-13Well 8-1A & 8-2A Treatment (GW)SE1<4<40none
2023-08-08Wells 1-18,1-17A, 1-13A Treatment (GW)SE1<4<40none
2023-08-08Wells 23-1 & 23-2 Treatment (GW)SE1<4<40none
2023-08-08Wells 7-3 Treatment (GW)SE1<4<40none
2023-09-20Plant 24 (24-2A) (GW)SE1n/an/an/anone
2023-09-20Well 20-1 Treatment (GW)SE1<4<40none
2023-09-20Well 5-R Treatment (GW)SE1<4<40none
2023-10-18Wells 15-1A & 15-2A Treatment (GW)SE2<4<40none
2023-10-18Wells 4-16 & 4-17 Treatment (GW)SE2<4<40none
2023-11-17Well 10-1 Treatment (GW)SE2<4<40none
2023-11-17Wells 12-1 & 12-2 Treatment (GW)SE2<4<40none
2023-11-17Wells 17-1 & 17-2 Treatment (GW)SE2<4<40none
2023-12-05Wells 18-1 & 18-2 Treatment (GW)SE2<4<40none
2023-12-05Wells 19-1 & 19-2 Treatment (GW)SE2<4<40none
2023-12-15Plant 24 (24-2A) (GW)SE1<4<40none
2024-01-10Well 22-1 Treatment (GW)SE2<4<40none
2024-01-10Well 8-1A & 8-2A Treatment (GW)SE2<4<40none
2024-02-07Wells 1-18,1-17A, 1-13A Treatment (GW)SE2<4<40none
2024-02-07Wells 23-1 & 23-2 Treatment (GW)SE2<4<40.33none
2024-02-07Wells 7-3 Treatment (GW)SE2<4<40none
2024-03-01Plant 24 (24-2A) (GW)SE2<4<40none
2024-03-01Well 5-R Treatment (GW)SE2<45.11.04none
2024-05-09Well 2-1A Treatment (GW)SE2<4<40none
2024-05-09Well 20-1 Treatment (GW)SE2<4<40none
2025-07-15Well 6-1 Treatment (GW)SE2<4<40none
2025-08-13Well 6-1 Treatment (GW)SE2n/an/an/anone

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

1050 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

Plant 24 (24-2A) facility 90000 · sample point T90000 · groundwater

CompoundMRL2023-09-20
SE1
2023-12-15
SE1
2024-03-01
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 10-1 Treatment facility 04393 · sample point T04393 · groundwater

CompoundMRL2023-05-02
SE1
2023-11-17
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 2-1A Treatment facility 01602 · sample point T01602 · groundwater

CompoundMRL2023-06-22
SE1
2024-05-09
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 20-1 Treatment facility 07548 · sample point T07548 · groundwater

CompoundMRL2023-09-20
SE1
2024-05-09
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 22-1 Treatment facility 07831 · sample point T07831 · groundwater

CompoundMRL2023-07-13
SE1
2024-01-10
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 5-R Treatment facility 55555 · sample point T55555 · groundwater

CompoundMRL2023-09-20
SE1
2024-03-01
SE2
PFHxS3 ppt< 36.3
PFNA4 ppt< 44.1
PFOS4 ppt< 45.1
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 6-1 Treatment facility 04405 · sample point T04405 · groundwater

CompoundMRL2023-07-13
SE1
2025-07-15
SE2
2025-08-13
SE2
11Cl-PF3OUdS5 ppt< 5< 5–
4:2 FTS3 ppt< 3< 3–
6:2 FTS5 ppt< 5< 5–
8:2 FTS5 ppt< 5< 5–
9Cl-PF3ONS2 ppt< 2< 2–
ADONA3 ppt< 3< 3–
HFPO-DA5 ppt< 5< 5–
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt< 20< 20–
NMeFOSAA6 ppt< 6–< 6
PFBA5 ppt< 5< 5–
PFBS3 ppt< 3< 3–
PFDA3 ppt< 3< 3–
PFDoA3 ppt< 3< 3–
PFEESA3 ppt< 3< 3–
PFHpA3 ppt< 3< 3–
PFHpS3 ppt< 3< 3–
PFHxA3 ppt< 3< 3–
PFHxS3 ppt< 3< 3–
PFMBA3 ppt< 3< 3–
PFMPA4 ppt< 4< 4–
PFNA4 ppt< 4< 4–
PFOA4 ppt< 4< 4–
PFOS4 ppt< 4< 4–
PFPeA3 ppt< 3< 3–
PFPeS4 ppt< 4< 4–
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt< 2< 2–
lithium9 µg/L14.9< 9–

Well 8-1A & 8-2A Treatment facility 13143 · sample point T13143 · groundwater

CompoundMRL2023-07-13
SE1
2024-01-10
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 1-18,1-17A, 1-13A Treatment facility 12918 · sample point T12918 · groundwater

CompoundMRL2023-08-08
SE1
2024-02-07
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 12-1 & 12-2 Treatment facility 04132 · sample point T04132 · groundwater

CompoundMRL2023-05-02
SE1
2023-05-17
SE1
2023-11-17
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Wells 15-1A & 15-2A Treatment facility 05121 · sample point T05121 · groundwater

CompoundMRL2023-04-11
SE1
2023-10-18
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 17-1 & 17-2 Treatment facility 05656 · sample point T05656 · groundwater

CompoundMRL2023-05-02
SE1
2023-05-17
SE1
2023-11-17
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Wells 18-1 & 18-2 Treatment facility 05653 · sample point T05653 · groundwater

CompoundMRL2023-06-22
SE1
2023-12-05
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 19-1 & 19-2 Treatment facility 06146 · sample point T06146 · groundwater

CompoundMRL2023-06-22
SE1
2023-12-05
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 23-1 & 23-2 Treatment facility 07855 · sample point T07855 · groundwater

CompoundMRL2023-08-08
SE1
2024-02-07
SE2
PFHxS3 ppt< 33.3
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 3-1A Treatment facility 01603 · sample point T01603 · groundwater

CompoundMRL2023-04-11
SE1
11Cl-PF3OUdS5 ppt< 5
4:2 FTS3 ppt< 3
6:2 FTS5 ppt< 5
8:2 FTS5 ppt< 5
9Cl-PF3ONS2 ppt< 2
ADONA3 ppt< 3
HFPO-DA5 ppt< 5
NEtFOSAA5 ppt< 5
NFDHA20 ppt< 20
NMeFOSAA6 ppt< 6
PFBA5 ppt< 5
PFBS3 ppt< 3
PFDA3 ppt< 3
PFDoA3 ppt< 3
PFEESA3 ppt< 3
PFHpA3 ppt< 3
PFHpS3 ppt< 3
PFHxA3 ppt< 3
PFHxS3 ppt< 3
PFMBA3 ppt< 3
PFMPA4 ppt< 4
PFNA4 ppt< 4
PFOA4 ppt< 4
PFOS4 ppt< 4
PFPeA3 ppt< 3
PFPeS4 ppt< 4
PFTA8 ppt< 8
PFTrDA7 ppt< 7
PFUnA2 ppt< 2
lithium9 µg/L< 9

Wells 4-16 & 4-17 Treatment facility 02613 · sample point T02613 · groundwater

CompoundMRL2023-04-11
SE1
2023-10-18
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 7-3 Treatment facility 09613 · sample point T09613 · groundwater

CompoundMRL2023-08-08
SE1
2024-02-07
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Statistics by compound

CompoundResultsDetectedHighest (date)Mean boundsKM medianP75P90P95
PFHxS356%6.3
2024-03-01
0.27–3.1<MRL<MRL<MRL3.3
PFNA353%4.1
2024-03-01
0.12–4<MRL<MRL<MRL<MRL
PFOS353%5.1
2024-03-01
0.15–4.03<MRL<MRL<MRL<MRL
lithium353%14.9
2023-07-13
0.43–9.17<MRL<MRL<MRL<MRL

Never detected (26): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFBA, PFBS, PFDA, PFDoA, PFEESA, PFHpA, PFHpS, PFHxA, PFMBA, PFMPA, PFOA, PFPeA, PFPeS, PFTA, PFTrDA, PFUnA.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-03 to 2026-06-17; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 171ad949e257 · 2026-10-18T04:10Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.